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Eicosanoids act in nodulation reactions to bacterial infections in newly 
emerged adult honey bees, Apis mellifera, but not in older foragers 




Nodulation is the first, and qualitatively predominant, cellular defense reaction to bacterial 
infections in insects. We tested the hypothesis that eicosanoids also mediate nodulation reactions 
to bacterial challenge in adults of a social insect, the honey bee, Apis mellifera. Treating newly-
emerged experimental bees with the eicosanoid biosynthesis inhibitor, dexamethasone, impaired 
nodulation reactions to bacterial infections, and the influence of dexamethasone was reversed by 
treating infected insects with arachidonic acid, an eicosanoid precursor. Several other eicosanoid 
biosynthesis inhibitors, including the cyclooxygenase inhibitor, indomethacin, and the dual 
cyclooxygenase/lipoxygenase inhibitor, phenidone, also impaired the ability of experimental 
honeybees to form nodules in reaction to bacterial challenge. The influence of phenidone on 
nodulation was expressed in a dose-dependent manner. However, in experiments with older 
honey bees foragers, similar bacterial challenge did not evoke nodulation reactions. We infer 
from our results that while eicosanoids mediate cellular immune responses to bacterial infections 
in newly emerged honey bees, and more broadly, in most insect species, nodulation reactions to 
bacterial challenge probably do not occur in all phases of insect life cycles. 
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